Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBIT (2020 - 2025)

Historic EBIT for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to -$339217.0.

  • Stemtech's EBIT rose 5265.44% to -$339217.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 5289.41%. This contributed to the annual value of -$2.4 million for FY2024, which is 4351.05% up from last year.
  • According to the latest figures from Q3 2025, Stemtech's EBIT is -$339217.0, which was up 5265.44% from -$300988.0 recorded in Q2 2025.
  • Over the past 5 years, Stemtech's EBIT peaked at $33163.0 during Q4 2024, and registered a low of -$3.4 million during Q3 2022.
  • Over the past 5 years, Stemtech's median EBIT value was -$716470.0 (recorded in 2024), while the average stood at -$878407.2.
  • In the last 5 years, Stemtech's EBIT crashed by 59299.59% in 2023 and then surged by 10232.4% in 2024.
  • Over the past 5 years, Stemtech's EBIT (Quarter) stood at -$1.8 million in 2021, then soared by 76.27% to -$432237.0 in 2022, then plummeted by 230.13% to -$1.4 million in 2023, then soared by 102.32% to $33163.0 in 2024, then plummeted by 1122.88% to -$339217.0 in 2025.
  • Its EBIT was -$339217.0 in Q3 2025, compared to -$300988.0 in Q2 2025 and -$1.2 million in Q1 2025.